Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. Some differences with influenza A

31Citations
Citations of this article
74Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: To evaluate the ability of peripheral blood inflammatory markers in predicating the typing of COVID-19, prognosis, and some differences between COVID-19 and influenza A patients. Methods: Clinical data on 285 cases laboratory-confirmed as SARS-CoV-2 infection were obtained from a Wuhan local hospital's electronic medical records according to previously designed standardized data collection forms. Additional 446 Influenza A outpatients’ hematologic data were enrolled for comparison. Results: NLR, SII, RLR, PLR, HsCRP, and IL-6 were significant higher and LMR was lower in severe COVID-19 patients than in mild COVID-19 patients (p

Cite

CITATION STYLE

APA

Zhao, Y., Yu, C., Ni, W., Shen, H., Qiu, M., & Zhao, Y. (2021). Peripheral blood inflammatory markers in predicting prognosis in patients with COVID-19. Some differences with influenza A. Journal of Clinical Laboratory Analysis, 35(1). https://doi.org/10.1002/jcla.23657

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free